CD95 ligand expression in dedifferentiated breast cancer (Q56975238)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

CD95 ligand expression in dedifferentiated breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

9

Matthias W. Beckmann

0 references

Régis Josien

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

9

Beckmann MW

1 reference

1 November 2019

Markus M�schen

1

0 references

Cordula Moers

2

0 references

Ulrich Warskulat

3

0 references

Dieter Niederacher

4

0 references

Beate Betz

5

0 references

Jos Even

6

0 references

Annick Lim

7

0 references

R�gis Josien

8

0 references

Dieter H�ussinger

10

0 references

Müschen M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Moers C

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Warskulat U

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Niederacher D

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Betz B

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Even J

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Lim A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Häussinger D

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

November 1999

0 references

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

378-386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10547600%20AND%20SRC:MED&resulttype=core&format=json

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Fas ligand in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Metalloproteinase-mediated release of human Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Downregulation of Fas ligand by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Impairment of Fas-antigen expression in adriamycin-resistant but not TNF-resistant MCF7 tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Antitumor effect of locally produced CD95 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Inhibition of the alloantibody response by CD95 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in human embryonal carcinoma cells by interferon gamma and all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199911%29189%3A3%3C378%3A%3AAID-PATH439%3E3.0.CO%3B2-D

10.1002/(SICI)1096-9896(199911)189:3<378::AID-PATH439>3.0.CO;2-D

21 January 2018

Identifiers

DOI

0 references

1 reference